Anthony Alberg to Polymorphism, Genetic
This is a "connection" page, showing publications Anthony Alberg has written about Polymorphism, Genetic.
Connection Strength
0.557
-
N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer. Cancer Detect Prev. 2004; 28(3):187-93.
Score: 0.207
-
Association of matrix metalloproteinase-1 polymorphisms with risk of COPD and lung cancer and survival in lung cancer. Anticancer Res. 2012 Sep; 32(9):3917-22.
Score: 0.094
-
Childhood exposure to secondhand smoke and functional mannose binding lectin polymorphisms are associated with increased lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2009 Dec; 18(12):3375-83.
Score: 0.078
-
Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis. 2004 Dec; 25(12):2467-72.
Score: 0.054
-
XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev. 2004 Aug; 13(8):1271-5.
Score: 0.054
-
Association between CYP17 polymorphisms and the development of breast cancer. Cancer Epidemiol Biomarkers Prev. 1998 Oct; 7(10):945-9.
Score: 0.036
-
Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst. 1998 Apr 01; 90(7):512-8.
Score: 0.035